Product Information
BUTALBITAL-ACETAMINOPHEN 50-300 MG TAB is a generic product labeled by Quagen Pharmaceuticals LLC, priced at $1.5324 per EA under NDC 70752014710. Its NADAC has been published 85 times since Nov 13, 2024.
Strength
300; 50 mg/1; mg/1
Manufacturer
Quagen Pharmaceuticals LLCNDC
70752014710
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
12/17/2025
Active Ingredients
ACETAMINOPHEN; BUTALBITALApproval Type
Generic (ANDA)
FDA Application
ANDA214305On Market Since
5/1/2024
Pharmacological Classes
Price Statistics
The NADAC for BUTALBITAL-ACETAMINOPHEN 50-300 MG TAB has been published 85 times since Nov 13, 2024, and over the history we have for it it has declined 52.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.5324 per EA |
|---|---|
| All-time high | $3.5911 (Dec 11, 2024) |
| All-time low | $1.5117 (Oct 22, 2025) |
| 52-week high | $1.8264 |
| 52-week low | $1.5117 |
| Median price | $1.6202 |
| Average price | $2.0034 |
| Largest weekly change | -16.6% (Mar 19, 2025) |
| Weeks tracked | 85 |
| Tracking since | Nov 13, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the BUTALBITAL and ACETAMINOPHEN market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of BUTALBITAL-ACETAMINOPHEN 50-300 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for BUTALBITAL-ACETAMINOPHEN 50-300 MG TAB, manufactured by Quagen Pharmaceuticals LLC, is $1.5324 per EA (NDC 70752014710), effective Jun 24, 2026.
How has the price of BUTALBITAL-ACETAMINOPHEN 50-300 MG TAB changed over time?
Over the history we have for it, the NADAC for BUTALBITAL-ACETAMINOPHEN 50-300 MG TAB has declined 52.0%. It has been tracked across 85 weekly CMS publications since Nov 13, 2024.
What are the highest and lowest recorded NADAC prices for BUTALBITAL-ACETAMINOPHEN 50-300 MG TAB?
Since Nov 13, 2024, the NADAC for BUTALBITAL-ACETAMINOPHEN 50-300 MG TAB has ranged from a low of $1.5117 (Oct 22, 2025) to a high of $3.5911 (Dec 11, 2024), with a median of $1.6202 per EA.
Are there cheaper alternatives to BUTALBITAL-ACETAMINOPHEN 50-300 MG TAB?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of BUTALBITAL-ACETAMINOPHEN 50-300 MG TAB, so no direct lower-cost alternative is listed.
Who manufactures BUTALBITAL-ACETAMINOPHEN 50-300 MG TAB?
BUTALBITAL-ACETAMINOPHEN 50-300 MG TAB (NDC 70752014710) is labeled by Quagen Pharmaceuticals LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification